Evidence map›Paper›PMID 34132395›Full record

Trial reportBritish journal of haematology2021

Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.

Onima Chowdhury, Hannah Bruguier, Garry Mallett, Nikolaos Sousos, Kirsty Crozier, Caroline Allman, David Eyre, Sheila Lumley, Marie Strickland, Christina S Karali and 6 more

Open access · hybridAbstract readClinical TrialLetter
PubMed Full text at PMC Publisher
In one paragraph

Trial report in British journal of haematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 8 pooled it
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 8 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.Annals of oncology : official journal of the European Society for Medical Oncology · 2022
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. COVID-19 vaccination in cancer patients: a narrative review.The Journal of international medical research · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Onima ChowdhuryMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-8150-4088
Hannah BruguierDepartment of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
Garry MallettDepartment of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
Nikolaos SousosMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-9100-2954
Kirsty CrozierDepartment of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
Caroline AllmanDepartment of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
David EyreNuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK.
Sheila LumleyDepartment of Microbiology, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
Marie StricklandMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Christina S KaraliMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Lauren MurphyMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Alex SternbergDepartment of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
Katie JefferyDepartment of Microbiology, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
Adam J MeadMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-8522-1002
Andy PeniketDepartment of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
Bethan PsailaMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-8198-9663
Churchill Hospital · GBNational Institute for Health Research · GBUniversity of Oxford · GBOxford University Hospitals NHS Trust · GB

Funding

Cancer Research UK 26988Cancer Research UK 27125Cancer Research UK 27723Cancer Research UK 28051Cancer Research UK 29034Medical Research Council G84/6443Medical Research Council MR/L006340/1Medical Research Council MR/T005211/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

VaccinationAdultAgedAged, 80 and overAntibody FormationBNT162 VaccineChAdOx1 nCoV-19COVID-19COVID-19 VaccinesFemaleHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMiddle AgedSARS-CoV-2BNT162 VaccineChAdOx1 nCoV-19COVID-19 Vaccines

Identifiers

PMID34132395
PMCPMC8444839
OpenAlexW3170814150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.